Complementary Pharmacological Treatment and Therapeutic Prospects for COVID-19
JA De Soto, F DSSc, ST Hakim, D Fouast - 2020 - osf.io
BACKGROUND: The COVID-19 outbreak has led to a world-wide pandemic that has
infected over two million people and caused over one hundred thousand deaths. The virus …
infected over two million people and caused over one hundred thousand deaths. The virus …
[HTML][HTML] Pathophysiology and potential therapeutic candidates for COVID-19: a poorly understood arena
A Samaddar, M Grover, VL Nag - Frontiers in pharmacology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), an acute onset pneumonia caused by a novel
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …
[HTML][HTML] Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
YW Zhou, Y Xie, LS Tang, D Pu, YJ Zhu… - Signal transduction and …, 2021 - nature.com
Owing to the limitations of the present efforts on drug discovery against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of the understanding of the …
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of the understanding of the …
Evolving pharmaceutical therapies for confronting COVID-19: An overview
R Ghai, K Nagarajan, T Mishra, S Vats… - AIP Conference …, 2022 - pubs.aip.org
December 2019 was marked by the arrival of the novel coronavirus, which has now
reportedly resulted in 4,200,412 deaths (as ofJuly 30, 2021) world-wide. Although the …
reportedly resulted in 4,200,412 deaths (as ofJuly 30, 2021) world-wide. Although the …
[PDF][PDF] Distinctive Therapeutic Strategies against Corona Virus19 (COVID-19): A Pharmacological Review.
YA Nomier, DS Rao, AH Suhaqi… - Systematic Reviews in …, 2020 - researchgate.net
Coronaviruses (CoVs) are RNA viruses threatened the global health. The causative
microorganism, causing coronavirus disease-2019 (COVID-19), is known as (novel …
microorganism, causing coronavirus disease-2019 (COVID-19), is known as (novel …
Current scenario and future prospect in the management of COVID-19
P Borah, PK Deb, S Deka… - Current medicinal …, 2021 - ingentaconnect.com
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …
assessment, rapid spreading ability, and propensity to precipitate severe disease in …
An Overview on Anti-COVID-19 Drug Achievements and Challenges Ahead
M Valipour, H Irannejad, H Keyvani - ACS Pharmacology & …, 2023 - ACS Publications
The appearance of several coronavirus pandemics/epidemics during the last two decades
(SARS-CoV-1 in 2002, MERS-CoV in 2012, and SARS-CoV-2 in 2019) indicates that …
(SARS-CoV-1 in 2002, MERS-CoV in 2012, and SARS-CoV-2 in 2019) indicates that …
Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic
R Bhandari, G Khanna, A Kuhad - European Journal of Pharmacology, 2021 - Elsevier
Coronaviruses are pleomorphic, enveloped, or spherical viruses, which have a size ranging
from 80 to 120 nm. These viruses act on receptors that cause the triggering of fusion …
from 80 to 120 nm. These viruses act on receptors that cause the triggering of fusion …
[HTML][HTML] Pipeline pharmacological therapies in clinical trial for COVID-19 pandemic: a recent update
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),
responsible for causing coronavirus disease 2019 (COVID-19), marked the third time in the …
responsible for causing coronavirus disease 2019 (COVID-19), marked the third time in the …
[HTML][HTML] Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …